Cargando…
Nucleobindin‐2/nesfatin‐1 enhances the cell proliferation, migration, invasion and epithelial‐mesenchymal transition in gastric carcinoma
Nesfatin‐1, a newly discovered adipokine derived from nucleobindin‐2 (NUCB2), has been described as a new prognostic marker in cancers. This study aimed to explore the functional role of NUCB2/nesfatin‐1 in the cell proliferation, migration and invasion in gastric carcinoma (GC). The expressions of...
Autores principales: | Ren, Le, Bao, Deming, Wang, Liming, Xu, Qin, Xu, Yayun, Shi, Zhenwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549493/ https://www.ncbi.nlm.nih.gov/pubmed/36065769 http://dx.doi.org/10.1111/jcmm.17522 |
Ejemplares similares
-
Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer
por: Liu, Guang-Ming, et al.
Publicado: (2018) -
Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer
por: Kan, Jung-Yu, et al.
Publicado: (2016) -
Nucleobindin-2/Nesfatin-1—A New Cancer Related Molecule?
por: Kmiecik, Alicja M., et al.
Publicado: (2021) -
Nucleobindin-2 enhances the epithelial-mesenchymal transition in renal cell carcinoma
por: Tao, Ran, et al.
Publicado: (2020) -
Transgenic mice overexpressing nesfatin/nucleobindin-2 are susceptible to high-fat diet-induced obesity
por: Shimizu, H, et al.
Publicado: (2016)